Calcitonin News and Research

RSS
Calcitonin is a 32-amino acid linear polypeptide hormone that is produced in humans primarily by the parafollicular cells (also known as C-cells) of the thyroid, and in many other animals in the ultimobranchial body.
PCT screening could be promising tool to help shorten hospital stays, reduce costs for sepsis patients

PCT screening could be promising tool to help shorten hospital stays, reduce costs for sepsis patients

Scientists devise new radiation-free probe for imaging molecules in the brain

Scientists devise new radiation-free probe for imaging molecules in the brain

Using biomarkers to diagnose sepsis: an interview with Jordi Trafi

Using biomarkers to diagnose sepsis: an interview with Jordi Trafi

New drug for chronic migraine may reduce headache hours in few days

New drug for chronic migraine may reduce headache hours in few days

Migraine drug has quick onset of action

Migraine drug has quick onset of action

Additional drug treatment options to prevent migraine may offer hope to sufferers

Additional drug treatment options to prevent migraine may offer hope to sufferers

More phase II success for CGRP migraine prevention strategy

More phase II success for CGRP migraine prevention strategy

Oral formulation of insulin shows promise in management of blood glucose in diabetic rats

Oral formulation of insulin shows promise in management of blood glucose in diabetic rats

TARSA Therapeutics' TBRIA NDA accepted by FDA for review

TARSA Therapeutics' TBRIA NDA accepted by FDA for review

Calcitonin-gene related peptide antibody inhibition shows migraine prevention promise

Calcitonin-gene related peptide antibody inhibition shows migraine prevention promise

EKF’s new Altair 240 revealed to UK audience at IBMS 2015

EKF’s new Altair 240 revealed to UK audience at IBMS 2015

MU researchers identify age-related cause of arterial dysfunction

MU researchers identify age-related cause of arterial dysfunction

Amgen, Novartis collaborate for Alzheimer's disease and migraine programs

Amgen, Novartis collaborate for Alzheimer's disease and migraine programs

Allergan agrees to acquire exclusive worldwide rights to Merck's CGRP migraine development program

Allergan agrees to acquire exclusive worldwide rights to Merck's CGRP migraine development program

Lilly announces positive results from LY2951742 Phase 2b study in patients with episodic migraine

Lilly announces positive results from LY2951742 Phase 2b study in patients with episodic migraine

CGRP monoclonal antibodies show promise in treating migraine

CGRP monoclonal antibodies show promise in treating migraine

Once-weekly Trulicity 0.75 mg shows promising results in Japanese patients with type 2 diabetes

Once-weekly Trulicity 0.75 mg shows promising results in Japanese patients with type 2 diabetes

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

EKF introduces specific biomarker test for early sepsis identification

EKF introduces specific biomarker test for early sepsis identification

FDA approves Novo Nordisk’s weight loss injection, Saxenda

FDA approves Novo Nordisk’s weight loss injection, Saxenda